Community advisory boards (CAB) at OUCRU consist of representatives from the public and researchers, doctors, and coordinators from OUCRU. The two groups will discuss and exchange information that will help for research, on a particular topic (e.g. COVID-19), or for a particular target group (e.g., adolescents). The discussion results help the researchers or doctors understand more about the public concerns on a certain topic and get feedback from the community that can be beneficial to their work and/or research. On the other hand, the board meeting is a chance for community members to meet researchers and doctors directly and have their questions answered. OUCRU organises two such groups: the Hepatitis C Community Advisory Board and the Health Research Advisory Board.
The below infographic explains how the advisory board works at OUCRU and how to join.
The video below, produced by the Public and Community Engagement team, features interviews with researchers who have received valuable feedback from the Community Advisory Group at OUCRU.
Since October 2021
2020 – now
Seed Awards
This project aimed to identify feasible solutions for promoting the practice of writing a farming diary. The aim of the farming diary was to improve the recording of antibiotics usage and expenditure on- farm, which in turn would improve the awareness toward responsible use of antibiotics. To do that, we established and developed the capability for a Community Advisory Board (CAB) which would act as a bridge between the research group and the communities involved in our research.
Stock image by Freepik
2020
In this project, 8 to 12 children, consented and enrolled in the SURE trial were invited to join the Child and Adolescent Advisory Group (CAAG). Insightful data was collected through this preliminary project allowing researchers to better understand the perceptions, emotions and expectations of sick children enrolled in a clinical trial. Read More
2020
We established a Community Advisory Board (CAB) in Jayapura, Papua Province, as part of the ‘MetLep’ Trial. This trial is seeking to understand the efficacy and tolerability of using Metformin in combination with standard multidrug treatment for multibacillary leprosy.